|
EXOG expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.44089209850063E-16 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62947433324234E-12 |
| Normal-vs-Stage2 |
5.057100E-03 |
| Normal-vs-Stage3 |
3.155500E-02 |
| Normal-vs-Stage4 |
6.158600E-01 |
| Stage1-vs-Stage2 |
7.539800E-01 |
| Stage1-vs-Stage3 |
1.394820E-04 |
| Stage1-vs-Stage4 |
6.040100E-03 |
| Stage2-vs-Stage3 |
7.737700E-02 |
| Stage2-vs-Stage4 |
2.832100E-02 |
| Stage3-vs-Stage4 |
3.689800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.63669078290241E-12 |
| Normal-vs-AfricanAmerican |
4.78370000278616E-08 |
| Normal-vs-Asian |
4.937700E-02 |
| Caucasian-vs-AfricanAmerican |
7.655000E-01 |
| Caucasian-vs-Asian |
7.351800E-01 |
| AfricanAmerican-vs-Asian |
6.298800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62525548574877E-12 |
| Normal-vs-Female |
5.40169999840856E-08 |
| Male-vs-Female |
4.540000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.238380E-04 |
| Normal-vs-Extreme_Weight |
1.59979995917325E-09 |
| Normal-vs-Obese |
2.25039999968146E-07 |
| Normal-vs-Extreme_Obese |
1.334140E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.540600E-01 |
| Normal_Weight-vs-Obese |
3.544600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.698430E-01 |
| Extreme_Weight-vs-Obese |
9.018800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.464400E-01 |
| Obese-vs-Extreme_Obese |
4.343200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.737000E-03 |
| Normal-vs-Age(41-60Yrs) |
1.82043269347787E-12 |
| Normal-vs-Age(61-80Yrs) |
2.51298981623904E-12 |
| Normal-vs-Age(81-100Yrs) |
1.961810E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.844800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.912000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.812500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.327600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.346100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.757100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
2.628100E-02 |
| Normal-VS-KIRP CIMP |
1.493830E-02 |
| Normal-VS-Unclassified PRCC |
9.66970000000344E-05 |
| Type1 PRCC-VS-Type2 PRCC |
4.41424674590962E-13 |
| Type1 PRCC-VS-KIRP CIMP |
5.42570000039433E-09 |
| Type1 PRCC-VS-Unclassified PRCC |
1.446020E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.637600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.216500E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
9.799400E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.6362000000012E-05 |
| Normal-vs-N1 |
3.702500E-02 |
| Normal-vs-N2 |
1.418570E-01 |
| N0-vs-N1 |
6.483900E-03 |
| N0-vs-N2 |
5.166100E-02 |
| N1-vs-N2 |
2.371800E-02 |
|
|
